Ngā hua rapu - Eleonora Teplinsky

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer

    A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer mā Komal Jhaveri, Rui Wang, Eleonora Teplinsky, Sarat Chandarlapaty, David B. Solit, Karen A. Cadoo, James L. Speyer, Gabriella D’Andrea, Sylvia Adams, Sujata Patil, Sofia Haque, Tara O’Neill, Kent Friedman, Francisco J. Esteva, Clifford A. Hudis, Shanu Modi

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy

    Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy mā Komal Jhaveri, Eleonora Teplinsky, Deborah Silvera, Amanda Valeta-Magara, Rezina Arju, Shah Giashuddin, Yasmeen Sarfraz, Melissa Alexander, Farbod Darvishian, Paul H. Levine, Salman Hashmi, Ladan Zolfaghari, Heather J. Hoffman, Baljit Singh, Judith D. Goldberg, Tsivia Hochman, Silvia C. Formenti, Francisco J. Esteva, Meena S. Moran, Robert J. Schneider

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: